Pankaj Bhargava, M.D.

About

Dr. Pankaj Bhargava is an Entrepreneur Partner at MPM BioImpact. He is the CEO of portfolio company āshibio and serves on the Board of Directors of Tizona Therapeutics. Pankaj previously served as the interim Chief Medical Officer of Aktis Oncology (NASDAQ: AKTS) and on the Board of Directors of Firefly Biologics (acquired by Johnson & Johnson). Prior to joining MPM BioImpact, Pankaj served as Vice President and Head of the Oncology Therapeutic Area at Gilead Sciences where he was responsible for driving oncology strategy and execution across programs spanning preclinical development to post-marketing commitments.

Source (opens in a new tab)